Helena J. H. van der Pal
Princess Máxima Center(NL)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Family Support in Illness, Chemotherapy-induced cardiotoxicity and mitigation, Palliative Care and End-of-Life Issues
Most-Cited Works
- → 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)(2022)2,508 cited
- → Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer(2007)867 cited
- → Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children(2011)392 cited
- → Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review(2002)354 cited
- → High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors(2012)321 cited
- → Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study(2006)282 cited
- → Individual Prediction of Heart Failure Among Childhood Cancer Survivors(2014)270 cited
- → A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer(2015)270 cited
- → Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity(2019)231 cited